BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
|
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Last 5 Year Income Statement History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹45 Cr | ₹78 Cr | ₹85 Cr | ₹67 Cr | ₹84 Cr |
Sales | ₹45 Cr | ₹78 Cr | ₹85 Cr | ₹67 Cr | ₹84 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | - | - | - | - | - |
Revenue from property development | - | - | - | - | - |
Other Operational Income | - | - | - | - | - |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹45 Cr | ₹78 Cr | ₹85 Cr | ₹67 Cr | ₹84 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹5.95 Cr | ₹0.45 Cr | ₹20 Cr | ₹-13 Cr | ₹-14 Cr |
Raw Material Consumed | ₹33 Cr | ₹59 Cr | ₹61 Cr | ₹69 Cr | ₹84 Cr |
Opening Raw Materials | ₹27 Cr | ₹6.29 Cr | ₹22 Cr | ₹0.01 Cr | ₹1.47 Cr |
Purchases Raw Materials | ₹6.32 Cr | ₹80 Cr | ₹46 Cr | ₹91 Cr | ₹83 Cr |
Closing Raw Materials | ₹0.26 Cr | ₹27 Cr | ₹6.29 Cr | ₹22 Cr | ₹0.01 Cr |
Other Direct Purchases / Brought in cost | - | - | - | - | - |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹1.36 Cr | ₹1.69 Cr | ₹1.55 Cr | ₹1.85 Cr | ₹1.74 Cr |
Electricity & Power | ₹1.36 Cr | ₹1.69 Cr | ₹1.55 Cr | ₹1.85 Cr | ₹1.74 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹15 Cr | ₹14 Cr | ₹14 Cr | ₹11 Cr | ₹9.78 Cr |
Salaries, Wages & Bonus | ₹13 Cr | ₹12 Cr | ₹9.33 Cr | ₹10 Cr | ₹8.63 Cr |
Contributions to EPF & Pension Funds | ₹1.36 Cr | ₹1.16 Cr | ₹0.96 Cr | ₹0.99 Cr | ₹0.86 Cr |
Workmen and Staff Welfare Expenses | - | ₹0.01 Cr | ₹0.08 Cr | ₹0.09 Cr | ₹0.10 Cr |
Other Employees Cost | ₹1.00 Cr | ₹1.05 Cr | ₹4.08 Cr | ₹0.03 Cr | ₹0.20 Cr |
Other Manufacturing Expenses | ₹3.38 Cr | ₹6.65 Cr | ₹7.82 Cr | ₹6.85 Cr | ₹9.56 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | ₹0.16 Cr | ₹0.22 Cr | ₹0.16 Cr | ₹0.36 Cr | ₹0.01 Cr |
Packing Material Consumed | ₹2.67 Cr | ₹5.74 Cr | ₹6.68 Cr | ₹5.35 Cr | ₹8.51 Cr |
Other Mfg Exp | ₹0.56 Cr | ₹0.69 Cr | ₹0.98 Cr | ₹1.15 Cr | ₹1.04 Cr |
General and Administration Expenses | ₹1.18 Cr | ₹0.71 Cr | ₹0.58 Cr | ₹0.63 Cr | ₹0.44 Cr |
Rent , Rates & Taxes | - | - | - | - | - |
Insurance | ₹0.21 Cr | ₹0.06 Cr | ₹0.07 Cr | ₹0.06 Cr | ₹0.02 Cr |
Printing and stationery | ₹0.01 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.00 Cr |
Professional and legal fees | ₹0.48 Cr | ₹0.13 Cr | ₹0.10 Cr | ₹0.12 Cr | ₹0.09 Cr |
Traveling and conveyance | ₹0.13 Cr | ₹0.16 Cr | ₹0.14 Cr | ₹0.17 Cr | ₹0.13 Cr |
Other Administration | ₹0.37 Cr | ₹0.35 Cr | ₹0.26 Cr | ₹0.26 Cr | ₹0.19 Cr |
Selling and Distribution Expenses | ₹0.35 Cr | ₹0.50 Cr | ₹0.58 Cr | ₹0.57 Cr | ₹0.71 Cr |
Advertisement & Sales Promotion | ₹0.01 Cr | ₹0.02 Cr | ₹0.01 Cr | ₹0.02 Cr | ₹0.01 Cr |
Sales Commissions & Incentives | - | - | - | - | - |
Freight and Forwarding | ₹0.34 Cr | ₹0.48 Cr | ₹0.57 Cr | ₹0.55 Cr | ₹0.70 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | - | - | - | - | - |
Miscellaneous Expenses | ₹0.26 Cr | ₹0.33 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr |
Bad debts /advances written off | - | - | - | - | - |
Provision for doubtful debts | - | - | - | - | - |
Losson disposal of fixed assets(net) | - | - | - | - | - |
Losson foreign exchange fluctuations | ₹0.18 Cr | - | - | - | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹0.08 Cr | ₹0.33 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹61 Cr | ₹83 Cr | ₹106 Cr | ₹77 Cr | ₹93 Cr |
Operating Profit (Excl OI) | ₹-16 Cr | ₹-4.97 Cr | ₹-21 Cr | ₹-10 Cr | ₹-9.32 Cr |
Other Income | ₹1.06 Cr | ₹1.10 Cr | ₹1.68 Cr | ₹1.18 Cr | ₹4.23 Cr |
Interest Received | ₹0.47 Cr | ₹0.55 Cr | ₹0.68 Cr | ₹0.91 Cr | ₹0.72 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | - | - | - | - | - |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | - | - | - | ₹0.04 Cr | - |
Foreign Exchange Gains | - | ₹0.49 Cr | ₹0.37 Cr | ₹0.12 Cr | ₹3.27 Cr |
Others | ₹0.59 Cr | ₹0.06 Cr | ₹0.62 Cr | ₹0.11 Cr | ₹0.24 Cr |
Operating Profit | ₹-15 Cr | ₹-3.87 Cr | ₹-19 Cr | ₹-9.21 Cr | ₹-5.09 Cr |
Interest | ₹7.06 Cr | ₹5.60 Cr | ₹4.79 Cr | ₹4.75 Cr | ₹2.00 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹0.10 Cr | ₹0.50 Cr | ₹0.43 Cr | ₹0.69 Cr | ₹0.55 Cr |
Other Interest | ₹6.96 Cr | ₹5.11 Cr | ₹4.36 Cr | ₹4.06 Cr | ₹1.46 Cr |
PBDT | ₹-22 Cr | ₹-9.48 Cr | ₹-24 Cr | ₹-14 Cr | ₹-7.10 Cr |
Depreciation | ₹0.20 Cr | ₹0.21 Cr | ₹0.24 Cr | ₹0.24 Cr | ₹0.28 Cr |
Profit Before Taxation & Exceptional Items | ₹-22 Cr | ₹-9.69 Cr | ₹-24 Cr | ₹-14 Cr | ₹-7.37 Cr |
Exceptional Income / Expenses | - | - | - | - | - |
Profit Before Tax | ₹-22 Cr | ₹-9.69 Cr | ₹-24 Cr | ₹-14 Cr | ₹-7.37 Cr |
Provision for Tax | ₹-5.63 Cr | ₹-0.93 Cr | ₹-6.10 Cr | ₹-3.99 Cr | ₹-1.58 Cr |
Current Income Tax | - | - | - | - | - |
Deferred Tax | ₹-5.63 Cr | ₹-0.93 Cr | ₹-6.10 Cr | ₹-3.99 Cr | ₹-1.58 Cr |
Other taxes | - | - | - | - | - |
Profit After Tax | ₹-17 Cr | ₹-8.75 Cr | ₹-18 Cr | ₹-10 Cr | ₹-5.79 Cr |
Extra items | - | - | - | - | - |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹-50 Cr | ₹-41 Cr | ₹-23 Cr | ₹-13 Cr | ₹-5.69 Cr |
Appropriations | ₹-66 Cr | ₹-50 Cr | ₹-41 Cr | ₹-23 Cr | ₹-11 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | - | - | - | ₹-0.01 Cr | ₹1.02 Cr |
Equity Dividend % | - | - | - | - | - |
Earnings Per Share | ₹-3.85 | ₹-2.03 | ₹-4.19 | ₹-2.36 | ₹-1.34 |
Adjusted EPS | ₹-3.85 | ₹-2.03 | ₹-4.19 | ₹-2.36 | ₹-1.34 |
Compare Income Statement of peers of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | ₹102.0 Cr | 1.3% | -8.4% | -8.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,352.0 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
CIPLA | ₹120,035.0 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,461.4 Cr | -1% | -4% | 48.4% | Stock Analytics |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | 1.3% |
-8.4% |
-8.1% |
SENSEX | -1.9% |
-5% |
17.5% |
You may also like the below Video Courses